with SepsiSTAT®

ID and AST results in hours direct from blood are a reality.

When blood culture is too slow, the SepsiSTAT® system is an alternative path to ID and phenotypic AST results in hours, not days.



2-5 days for targeted antibiotic treatment is not good enough.

The challenges facing patients, physicians, and healthcare when sepsis and bloodstream infection are suspected are well documented.

Increased risk of mortality, the high burden on healthcare budgets, and antimicrobial resistance all conspire to reduce the life chances of patients with sepsis when the time for effective treatment is a matter of life or death.

The standard of care for diagnosing a patient with suspected bloodstream infection is a system of culture-based methods that rely on the growth of organisms over 1-5 days where only then can the physician target antibiotics effectively.

This culturing step is a barrier to speeding up time-to-result for thousands of existing instruments and the adoption of newer, novel technologies.



Think Fast with SepsiSTAT®

Re-inventing blood culture for ID and AST results in hours.

A direct from blood sample processing and organism detection system enabling ID & AST results to be reported before blood culture turns positive.1


Reference: 1. Data on file for Molecular and MALDI ToF ID, Phenotypic AST and Metagenomic sequencing ID.


SepsiSTAT® utilises novel processes for extraction, concentration, and enrichment of living organisms from whole blood.

A 12mL whole blood sample added to 12mL proprietary media is split into two simultaneous processes (SepsiPURE and SepsiTECT) each providing a concentrated output for downstream testing.

SepsiSTAT® a FAST alternative to traditional blood culture.

Performance data show Momentum’s technology to be a realistic alternative to blood culture and will accelerate all downstream workflow TTR.

Universal detection:

All organisms tested are detected including Mycobacteria, Candida & Cryptococcus.

Universal output:

Demonstrated on 3rd Party platforms showing significant improvement in Time To Result from current workflow.

Reduced risk of missing BSI:

Detection levels typically between 1-10 cfu/mL. Detection of viable non-culturable and slow-growing organisms.

Concordant with blood culture in a clinical setting.



SepsiSTAT® is an automated sample processor for random-access preparation of blood samples for SepsiTECT® and SepsiPURE®

The SepsiTECT® output can be analysed using any suitable qPCR instrument. The SepsiPURE® output is analysed using similar workflows to current standards.


About us

Driven by unmet needs when managing patients with Sepsis the team at Momentum Bioscience are creating innovative approaches that help healthcare professionals act faster and smarter when diagnosing bloodstream infection and targeting antimicrobial treatments to save lives.

If you would like more information about our technology and investment, get in touch.

Contact us


Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN

TEL: +44 (0)29 2167 7910


Head Office
Momentum Bioscience Ltd
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF

TEL: +44 (0)29 2167 7910